Increased risk of malignancy in patients aged over 50 with idiopathic inflammatory myositis compared to patients with osteoarthritis of the knee

References

• Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362(9388):971–82.
   PubMed Web of Science ®Google Scholar
• Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, de Visser M. 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. 2017;69(12):2271–82.
   PubMed Web of Science ®Google Scholar
• Levine SM. Cancer and myositis: new insights into an old association. Curr Opin Rheumatol. 2006;18(6):620–4.
   PubMed Web of Science ®Google Scholar
• Dobloug GC, Garen T, Brunborg C, Gran JT, Molberg O. Survival and cancer risk in an unselected and complete Norwegian Idiopathic Inflammatory Myopathy Cohort. Semin Arthritis Rheum. 2015;45(3):301–8.
   PubMed Web of Science ®Google Scholar
• Torres C, Belmonte R, Carmona L, Gomez-Reino FJ, Galindo M, Ramos B, et al. Survival, mortality and causes of death in inflammatory myopathies. Autoimmunity. 2006;39(3):205–15.
   PubMed Web of Science ®Google Scholar
• Dobloug GC, Svensson J, Lundberg IE, Holmqvist M. Mortality in idiopathic inflammatory myopathy: results from a Swedish Nationwide Population-Based Cohort Study. Ann Rheum Dis. 2018;77(1):40–7.
   PubMed Web of Science ®Google Scholar
• Marie I, Hachulla E, Hatron PY, Hellot MF, Levesque H, Devulder B, et al. Polymyositis and dermatomyositis: short term and long term outcome, and predictive factors of prognosis. J Rheumatol. 2001;28(10):2230–7.
   PubMed Web of Science ®Google Scholar
• Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357(9250):96–100.
   PubMed Web of Science ®Google Scholar
• Wang J, Guo G, Chen G, Wu B, Lu L, Bao L. Meta-analysis of the association of dermatomyositis and polymyositis with cancer. Br J Dermatol. 2013;169(4):838–47.
   PubMed Web of Science ®Google Scholar
• Leatham H, Schadt C, Chisolm S, Fretwell D, Chung L, Callen JP, et al. Evidence supports blind screening for internal malignancy in dermatomyositis: data from 2 large us dermatology cohorts. Medicine. 2018;97(2):e9639.
   PubMed Web of Science ®Google Scholar
• Yazici Y, Kagen LJ. The association of malignancy with myositis. Curr Opin Rheumatol. 2000;12(6):498–500.
   PubMed Web of Science ®Google Scholar
• Kuo CF, See LC, Yu KH, Chou IJ, Chang HC, Chiou MJ, et al. Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study. Br J Dermatol. 2011;165(6):1273–9.
   PubMed Web of Science ®Google Scholar
• Korea Biomedicine Industry Association. National Health Insurance System of Korea. Available from: http://www.kobia.kr/bbs/board.php?tbl=policy_report&mode=VIEW&num=41 [last accessed 27 Sep 2018].
   Google Scholar
• Park H-R, Im SGi, Kim H, Jung S-Y, Kim D, Jang EJ, et al. Validation of algorithms to identify knee osteoarthritis patients in the claims database. Int J Rheum Dis. 2019;22(5):890–6.
   PubMed Web of Science ®Google Scholar
• Seo HJ, Oh IH, Yoon SJ. A comparison of cancer incidence rates between the national cancer registry and insurance claims data in Korea. Asian Pac J Cancer Prev. 2012;13(12):6163–8.
   PubMedGoogle Scholar
• Antiochos BB, Brown LA, Li Z, Tosteson TD, Wortmann RL, Rigby WF. Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA. J Rheumatol. 2009;36(12):2704–10.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Wu CY, Huang YL, Wang CB, Shen JL, Chang YT. Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan. Arthritis Res Ther. 2010;12(2):R70.
   PubMed Web of Science ®Google Scholar
• Stockton D, Doherty VR, Brewster DH. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish Population-Based Cohort Study. Br J Cancer. 2001;85(1):41–5.
   PubMed Web of Science ®Google Scholar
• Chow WH, Gridley G, Mellemkjaer L, McLaughlin JK, Olsen JH, Fraumeni JF. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control. 1995;6(1):9–13.
   PubMed Web of Science ®Google Scholar
• Wang HL, Zhou YM, Zhu GZ, Yang Z, Hua BJ. Malignancy as a comorbidity in rheumatic diseases: a retrospective hospital-based study. Clin Rheumatol. 2018;37(1):81–5.
   PubMed Web of Science ®Google Scholar
• Yang Z, Lin F, Qin B, Liang Y, Zhong R. Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study. J Rheumatol. 2015;42(2):282–91.
   PubMed Web of Science ®Google Scholar
• Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, et al. The euromyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis. 2018;77(1):30–9.
   PubMed Web of Science ®Google Scholar
• Sun LM, Epplein M, Li CI, Vaughan TL, Weiss NS. Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles county and the San Francisco metropolitan area, 1992–2002. Am J Epidemiol. 2005;162(12):1174–8.
   PubMed Web of Science ®Google Scholar
• Luo J, Chia KS, Chia SE, Reilly M, Tan CS, Ye W. Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973–1997. Eur J Epidemiol. 2007;22(8):513–21.
   PubMed Web of Science ®Google Scholar
• Liu WC, Ho M, Koh WP, Tan AW, Ng PP, Chua SH, et al. An 11-year review of dermatomyositis in Asian patients. Ann Acad Med Singapore. 2010;39(11):843–7.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Wu CY, Shen JL. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study. Br J Dermatol. 2001;144(4):825–31.
   PubMed Web of Science ®Google Scholar
• Chen D, Yuan S, Wu X, Li H, Qiu Q, Zhan Z, et al. Incidence and predictive factors for malignancies with dermatomyositis: a cohort from southern china. Clin Exp Rheumatol. 2014;32(5):615–21.
   PubMed Web of Science ®Google Scholar
• Azuma K, Yamada H, Ohkubo M, Yamasaki Y, Yamasaki M, Mizushima M, et al. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis. Mod Rheumatol. 2011;21(2):178–83.
   PubMed Web of Science ®Google Scholar
• Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for dermatomyositis. American Academy of Dermatology. J Am Acad Dermatol. 1996;34(5 Pt 1):824–9.
   PubMedGoogle Scholar
• Sparsa A, Liozon E, Herrmann F, Ly K, Lebrun V, Soria P, et al. Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients. Arch Dermatol. 2002;138(7):885–90.
   PubMedGoogle Scholar
• Kaji K, Fujimoto M, Hasegawa M, Kondo M, Saito Y, Komura K, et al. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford). 2007;46(1):25–8.
   PubMed Web of Science ®Google Scholar
• Yang H, Peng Q, Yin L, Li S, Shi J, Zhang Y, et al. Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study. Arthritis Res Ther. 2017;19(1):259.
   PubMedGoogle Scholar
• Fang YF, Wu YJ, Kuo CF, Luo SF, Yu KH. Malignancy in dermatomyositis and polymyositis: analysis of 192 patients. Clin Rheumatol. 2016;35(8):1977–84.
   PubMed Web of Science ®Google Scholar
• Fardet L, Dupuy A, Gain M, Kettaneh A, Chérin P, Bachelez H, et al. Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis. Medicine (Baltimore). 2009;88(2):91–7.
   PubMed Web of Science ®Google Scholar
• Baecklund E, Smedby KE, Sutton LA, Askling J, Rosenquist R. Lymphoma development in patients with autoimmune and inflammatory disorders – what are the driving forces? Semin Cancer Biol. 2014;24:61–70.
   PubMed Web of Science ®Google Scholar
• Meyer A, Meyer N, Schaeffer M, Gottenberg JE, Geny B, Sibilia J. Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology (Oxford). 2015;54(1):50–63.
   PubMed Web of Science ®Google Scholar
• Cho SK, Kim H, Myung J, Nam E, Jung SY, Jang EJ, et al. Incidence and prevalence of idiopathic inflammatory myopathies in Korea: a nationwide population-based study. J Korean Med Sci. 2019;34(8):e55.
   PubMed Web of Science ®Google Scholar